4ajp: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:4ajp.png|left|200px]]
{{STRUCTURE_4ajp|  PDB=4ajp  |  SCENE=  }}  
{{STRUCTURE_4ajp|  PDB=4ajp  |  SCENE=  }}  
===Human LDHA in complex with 2-((4-(4-((3-((2-methyl-1,3-benzothiazol- 6yl)amino)-3-oxo-propyl)amino)-4-oxo-butyl)phenyl)methyl)propanedioic acid===
===Human LDHA in complex with 2-((4-(4-((3-((2-methyl-1,3-benzothiazol- 6yl)amino)-3-oxo-propyl)amino)-4-oxo-butyl)phenyl)methyl)propanedioic acid===
{{ABSTRACT_PUBMED_22417091}}


{{ABSTRACT_PUBMED_22417091}}
==Disease==
[[http://www.uniprot.org/uniprot/LDHA_HUMAN LDHA_HUMAN]] Defects in LDHA are the cause of glycogen storage disease type 11 (GSD11) [MIM:[http://omim.org/entry/612933 612933]]. A metabolic disorder that results in exertional myoglobinuria, pain, cramps and easy fatigue.<ref>PMID:2334430</ref>


==About this Structure==
==About this Structure==
Line 14: Line 13:


==Reference==
==Reference==
<ref group="xtra">PMID:022417091</ref><references group="xtra"/>
<ref group="xtra">PMID:022417091</ref><references group="xtra"/><references/>
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: L-lactate dehydrogenase]]
[[Category: L-lactate dehydrogenase]]